Cabaletta Bio, Inc. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €806.41K
    Gross profit
    -€403.20K
    SG&A expenses
    €30.75M
    R&D expenses
    €102.07M
    EBITDA
    -€118.15M
    D&A
    €1.17M
    EBIT
    -€129.12M
    Interest expenses
    €1.39M
    EBT
    -€124.31M
    Tax expenses
    €0.00
    Net income
    -€124.31M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €4.86M
    Changes in working capital
    €9.56M
    Operating cash flow
    -€90.18M
    Capex
    €1.36M
    Other investing cash flow
    €0.00
    Net investing cash flow
    -€22.06M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €86.95M
    Debt repayment
    -€2.59M
    Other financing cash flow
    -€421.30K
    Net financing cash flow
    €83.80M
    Foreign exchange effects
    €15.51K
    Net change in cash
    -€28.43M
    Cash at end of period
    €125.45M
    Free cash flow
    -€88.82M

    Balance sheet

    Cash and cash equivalents
    €125.45M
    Cash and short-term investments
    €167.73M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €3.21M
    Total current assets
    €170.94M
    Property, plant & equipment
    €20.32M
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €2.16M
    Total non-current assets
    €22.48M
    Total assets
    €193.42M
    Accounts payable
    €6.20M
    Short-term debt
    €17.59M
    Other current liabilities
    €12.00M
    Total current liabilities
    €35.79M
    Long-term debt
    €3.86M
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €3.86M
    Total liabilities
    €39.65M
    Common stock
    €861.55
    Retained earnings
    -€370.61M
    Other equity
    €861.55
    Total equity
    €153.77M
    Total liabilities and shareholders' equity
    €193.42M

    Company information

    Market capitalization
    €120.45M
    Employees
    161
    Enterprise Value
    -€13.48M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -80.8% Much better than peer group: -106.2%
    ROA
    -64.3% Much worse than peer group: -43.2%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -76.0%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€772.11K

    Notifications